CN Stock MarketDetailed Quotes

Walvax Biotechnology (300142)

Watchlist
  • 13.00
  • +0.11+0.85%
Market Closed Apr 30 15:00 CST
20.79BMarket Cap72.63P/E (TTM)

Walvax Biotechnology (300142) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Autonomous vaccine2.15B89.00%
Intermediate product250.49M10.36%
Technical services9.88M0.41%
Other business5.72M0.24%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Biological medicine2.42B100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region679.27M28.09%
Overseas region522.04M21.59%
South China region400.71M16.57%
Southwest Northwest region346.88M14.34%
Central China region256.31M10.60%
Northeast North China region213.01M8.81%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More